Immuneering (IMRX) Leases (2020 - 2024)
Historic Leases for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $3.7 million.
- Immuneering's Leases fell 821.06% to $3.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.7 million, marking a year-over-year decrease of 821.06%. This contributed to the annual value of $4.0 million for FY2023, which is 934.83% down from last year.
- As of Q3 2024, Immuneering's Leases stood at $3.7 million, which was down 821.06% from $3.8 million recorded in Q2 2024.
- Immuneering's 5-year Leases high stood at $5.3 million for Q4 2021, and its period low was $537181.0 during Q3 2021.
- Its 5-year average for Leases is $3.6 million, with a median of $4.1 million in 2023.
- Its Leases has fluctuated over the past 5 years, first soared by 76840.19% in 2021, then crashed by 1721.22% in 2022.
- Immuneering's Leases (Quarter) stood at $613103.0 in 2020, then surged by 768.4% to $5.3 million in 2021, then decreased by 17.21% to $4.4 million in 2022, then dropped by 9.35% to $4.0 million in 2023, then dropped by 6.19% to $3.7 million in 2024.
- Its Leases stands at $3.7 million for Q3 2024, versus $3.8 million for Q2 2024 and $3.9 million for Q1 2024.